SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GRAZI, Gian Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.934
AS - Asia 5.219
EU - Europa 1.816
SA - Sud America 1.375
Continente sconosciuto - Info sul continente non disponibili 522
AF - Africa 156
OC - Oceania 12
Totale 17.034
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.522
SG - Singapore 2.177
BR - Brasile 1.041
CN - Cina 770
HK - Hong Kong 600
IT - Italia 580
VN - Vietnam 541
BD - Bangladesh 345
FI - Finlandia 227
RU - Federazione Russa 204
ID - Indonesia 188
JP - Giappone 179
CA - Canada 178
GB - Regno Unito 178
FR - Francia 176
DE - Germania 159
IN - India 114
AR - Argentina 104
MX - Messico 102
CO - Colombia 60
UA - Ucraina 59
EC - Ecuador 56
NL - Olanda 55
TR - Turchia 54
ZA - Sudafrica 51
AT - Austria 48
IQ - Iraq 40
CL - Cile 32
VE - Venezuela 30
PK - Pakistan 28
JM - Giamaica 27
PY - Paraguay 27
SE - Svezia 26
CR - Costa Rica 25
ES - Italia 25
MA - Marocco 23
SA - Arabia Saudita 23
MY - Malesia 22
UZ - Uzbekistan 20
KE - Kenya 18
PH - Filippine 18
TT - Trinidad e Tobago 16
DZ - Algeria 15
TN - Tunisia 13
AE - Emirati Arabi Uniti 10
AZ - Azerbaigian 10
DO - Repubblica Dominicana 10
HN - Honduras 10
PE - Perù 10
AU - Australia 9
JO - Giordania 9
NP - Nepal 9
SV - El Salvador 9
BO - Bolivia 8
CH - Svizzera 8
EE - Estonia 8
EG - Egitto 8
IE - Irlanda 8
LT - Lituania 8
PL - Polonia 8
UY - Uruguay 7
AL - Albania 6
BH - Bahrain 6
IL - Israele 6
KR - Corea 6
KZ - Kazakistan 6
TW - Taiwan 6
BY - Bielorussia 5
ET - Etiopia 5
SN - Senegal 5
BE - Belgio 4
BS - Bahamas 4
GT - Guatemala 4
NI - Nicaragua 4
OM - Oman 4
BB - Barbados 3
DK - Danimarca 3
KW - Kuwait 3
LB - Libano 3
MO - Macao, regione amministrativa speciale della Cina 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
TH - Thailandia 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
EU - Europa 2
GD - Grenada 2
GP - Guadalupe 2
GR - Grecia 2
HT - Haiti 2
HU - Ungheria 2
IR - Iran 2
LC - Santa Lucia 2
LV - Lettonia 2
MN - Mongolia 2
PA - Panama 2
Totale 16.475
Salva come PNG Salva come JPEG
Città #
Singapore 1.139
Ashburn 1.062
San Jose 885
Santa Clara 833
Council Bluffs 657
Hong Kong 597
Fairfield 274
Beijing 273
Helsinki 219
Ho Chi Minh City 192
Tokyo 174
Chandler 165
New York 155
Lauterbourg 148
Jakarta 133
Hanoi 123
Houston 115
Woodbridge 103
Los Angeles 100
Dallas 93
São Paulo 83
Seattle 77
Toronto 75
Wilmington 75
Princeton 74
Chicago 73
Mexico City 71
Milan 70
Rome 63
Cambridge 58
Moscow 57
Orem 51
Boardman 46
San Diego 46
London 43
Nuremberg 43
Shanghai 41
Ann Arbor 40
Buffalo 33
Rio de Janeiro 32
Brasília 29
Montreal 29
Jacksonville 27
Brooklyn 26
Atlanta 25
Haiphong 23
Salt Lake City 23
San Francisco 23
Vienna 23
Baghdad 22
Quito 22
Belo Horizonte 21
Chennai 20
Da Nang 20
Naples 20
Bologna 19
Curitiba 19
Medellín 19
Newark 19
Frankfurt am Main 18
Guangzhou 18
Phoenix 18
Porto Alegre 18
Tashkent 18
Washington 18
Denver 17
Portsmouth 17
Biên Hòa 16
Falkenstein 16
Falls Church 16
San José 16
Caracas 15
Guayaquil 15
Turin 15
Ferrara 14
Fortaleza 14
Kingston 14
Manchester 14
Nairobi 14
Dhaka 13
Guarulhos 13
Istanbul 13
Johannesburg 13
Mumbai 13
Philadelphia 13
Tampa 13
Bari 12
Charlotte 12
Las Vegas 12
Queens 12
Amsterdam 11
Buenos Aires 11
Salvador 11
Asunción 10
Campinas 10
Hangzhou 10
Kuala Lumpur 10
Santiago 10
Amman 9
Ankara 9
Totale 9.581
Salva come PNG Salva come JPEG
Nome #
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 217
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells 188
The Immune Landscape of Cancer 186
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics 185
Tumor Regression Grade After Neoadjuvant Chemoradiation and Surgery for Low Rectal Cancer Evaluated by Multiple Correspondence Analysis: Ten Years as Minimum Follow-up 183
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality 180
Oncogenic Signaling Pathways in The Cancer Genome Atlas 159
A case report of giant hepatic hemangioma spontaneous regression in adult, non-cirrhotic patient and literature review 158
Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis 153
A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples 150
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers 148
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma 147
Early onset aggressive hereditary amyloidosis: report of an Italian family with TTR Arg47 mutation. 142
Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry 136
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily 134
ALPPS for primary and secondary liver tumors 130
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer 129
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation 126
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas 125
Comprehensive Characterization of Cancer Driver Genes and Mutations 125
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics 125
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines 120
Curative versus palliative treatments for recurrent hepatocellular carcinoma: a multicentric weighted comparison 120
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation 117
Genomic and Functional Approaches to Understanding Cancer Aneuploidy 116
Genetically driven CD39 expression shapes human tumor-infiltrating CD8+ T-cell functions 115
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer 113
Pathogenic Germline Variants in 10,389 Adult Cancers 113
Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma 113
Performance of comprehensive complication index and clavien‐dindo complication scoring system in liver surgery for hepatocellular carcinoma 112
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system 107
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients 106
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 106
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 106
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation 105
Wnt3a/b-Catenin signaling conditions differentiation of partially exhausted T-effector cells in human cancers 105
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 105
Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma 103
Renewed considerations on the utility (or the futility) of hepatic resections for breast cancer liver metastases 102
Hepatocellular carcinoma surgical and oncological trends in a national multicentric population: the HERCOLES experience 101
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria 100
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period 100
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging 100
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis 99
Association of polygenic risk score and bacterial toxins at screening colonoscopy with colorectal cancer progression: A multicenter case-control study 99
Forcing ATGL expression in hepatocarcinoma cells imposes glycolytic rewiring through PPAR-α/p300-mediated acetylation of p53 98
Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells 98
Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study 98
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer 97
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas 97
The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma 97
The Impact of Hospital Volume on Failure to Rescue after Liver Resection for Hepatocellular Carcinoma: Analysis from the HE.RC.O.LE.S. Italian Registry 96
Laboratory test variability and Model for End-Stage Liver Disease score calculation: effect on liver allocation and proposal for adjustment 96
Primary leiomyoma of the liver in an immunocompetent patient 95
The actin modulator hMENA regulates GAS6-AXL axis and pro-tumor cancer/stromal cell cooperation 94
Evolution of pancreatectomy with en bloc venous resection for pancreatic cancer in Italy. Retrospective cohort study on 425 cases in 10 pancreatic referral units 94
Current status of liver surgery for non-colorectal non-neuroendocrine liver metastases: the NON.LI.MET. Italian Society for Endoscopic Surgery and New Technologies (SICE) and Association of Italian Surgeons in Europe (ACIE) collaborative international survey 93
Down-staging of hepatocellular carcinoma prior to liver transplantation: the power of selection 93
The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study 93
Key components of a hepatobiliary surgery curriculum for general surgery residents: results of the FULCRUM International Delphi consensus 91
The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome 90
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients 90
Multiple hepatocellular carcinoma: Long-term outcomes following resection beyond actual guidelines. An Italian multicentric retrospective study 90
FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma 90
Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 89
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases 88
Outcome of Right Hepatectomies in Patients Older Than 70 Years 88
Multicohort and cross-platform validation of a prognostic Wnt signature in colorectal cancer 87
Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 87
Impact of a goal-directed fluid therapy on length of hospital stay and costs of hepatobiliarypancreatic surgery: A prospective observational study 87
Liver resection for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis of risk factors for intrahepatic recurrence 86
Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years 86
Multicentre evaluation of case volume in minimally invasive hepatectomy 86
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population 86
Efficacy of MELD score in predicting survival after liver retransplantation 85
Robotic Liver Resections: Application of Difficulty Score Systems to an Initial Experience. Is a Specific Robotic Difficulty Score Necessary? 85
Molecular Aging of Human Liver: An Epigenetic/Transcriptomic Signature 83
Benchmarking postoperative outcomes after open liver surgery for cirrhotic patients with hepatocellular carcinoma in a national cohort 83
Recommendations for management of patients with neuroendocrine liver metastases 82
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience 82
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation 82
Psychological Adaptation and Quality of Life of Adult Intestinal Transplant Recipients: University of Bologna Experience 82
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner? 81
Perspectives from Italy during the COVID-19 pandemic: nationwide survey-based focus on minimally invasive HPB surgery 81
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 81
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 80
The largest western experience on salvage hepatectomy for recurrent hepatocellular carcinoma: propensity score-matched analysis on behalf of He.RC.O.Le.Study Group 80
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma 79
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation 79
Long Term Follow-Up of Patients with De Novo Tumors after 1300 Liver Transplantations: A Case-Control Study 79
Improving the outcome of liver transplantation with very old donors with updated selection and management criteria 79
The peculiar aging of human liver: A geroscience perspective within transplant context 79
A bioluminescent mouse model of proliferation to highlight early stages of pancreatic cancer: A suitable tool for preclinical studies 78
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era 78
Blood transfusions and steatohepatitis are independent risk factors for complications following liver resection for colorectal cancer liver metastases 78
Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants 78
Hepatectomy Versus Sorafenib in Advanced Non-Metastatic Hepatocellular Carcinoma: A Real-Life Multicentric Weighted Comparison 78
Coping strategies in intestinal transplantation 77
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment 77
Is minimally invasive liver surgery a reasonable option in recurrent HCC? A snapshot from the I Go MILS registry 77
Totale 10.552
Salva come PNG Salva come JPEG
Categoria #
all - tutte 135.203
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 135.203
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022493 0 0 0 6 13 11 127 73 41 22 58 142
2022/2023798 75 45 8 50 46 398 9 41 64 4 35 23
2023/2024498 38 79 38 22 24 18 14 19 19 8 30 189
2024/20253.203 115 49 326 3 378 394 59 129 402 838 238 272
2025/20268.560 467 344 853 1.016 934 318 679 507 1.024 1.285 590 543
2026/20272.700 422 613 913 752 0 0 0 0 0 0 0 0
Totale 17.034